Cargando…

996. A Cluster-Randomized Trial of Adjuvanted Trivalent Influenza Vaccine vs. Standard Dose in US Nursing Homes

BACKGROUND: Pneumonia and influenza lead as vaccine-preventable infections among nursing home (NH) residents. Immunosenescence reduces vaccine response and protection from infections. More immunogenic vaccines, e.g., adjuvanted trivalent influenza vaccine [aTIV], can improve clinical outcomes. We ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gravenstein, Stefan, Davidson, H Edward, Mcconeghy, Kevin, Han, Lisa, Canaday, David, Saade, Elie, Baier, Rosa R, Mor, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253508/ http://dx.doi.org/10.1093/ofid/ofy210.833

Ejemplares similares

LB-19. Association between contract staffing and reported outbreaks of SARS-CoV-2 in a cluster-randomized trial of 965 U.S. nursing homes
por: McConeghy, Kevin, et al.
Publicado: (2020)

901. The Impact of Cost-Free On-Site Influenza Point of Care Antigen Testing on Influenza Detection in Nursing Homes
por: Abdul, Yasin, et al.
Publicado: (2023)

1953. Comparative Effectiveness of High- vs. Standard-Dose Influenza Vaccine on Hospitalization for Acute Myocardial Infarction in Nursing-Home Residents: A Post-hoc Analysis From a Large Cluster-Randomized Trial
por: Saade, Elie, et al.
Publicado: (2018)

2170. The National Burden of Pneumonia and Influenza in U.S. Nursing Homes, 2013–2015
por: Mcconeghy, Kevin, et al.
Publicado: (2018)

Feasibility of a cluster-randomized influenza vaccination trial in U.S. nursing homes: Lessons learned
por: Gravenstein, Stefan, et al.
Publicado: (2017)

Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review
por: Bosco, Elliott, et al.
Publicado: (2021)

25. Relative Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to Egg-Based Trivalent High-Dose Influenza Vaccine among U.S. Older Adults during 2019-20 Influenza Season
por: levin, myron J, et al.
Publicado: (2021)

Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019–2020 Influenza Season
por: Imran, Mahrukh, et al.
Publicado: (2022)

Infections, Hospitalizations, and Deaths Among US Nursing Home Residents With vs Without a SARS-CoV-2 Vaccine Booster
por: McConeghy, Kevin W., et al.
Publicado: (2022)

Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017–2018 Influenza Season
por: Pelton, Stephen I., et al.
Publicado: (2020)

Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents
por: Bardenheier, Barbara H., et al.
Publicado: (2021)

Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial
por: Schmader, Kenneth E., et al.
Publicado: (2021)

14. A Comprehensive Real-World Analysis to Compare Adjuvanted Trivalent Influenza Vaccine and Trivalent High Dose Influenza Vaccine by Age and Period of High Influenza Activity for the 2018–19 Season among U.S. Elderly
por: Postma, Maarten, et al.
Publicado: (2020)

Lute suites, BWV 996 & 997 Lautensuiten /
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1983)

29. Impact of Enhanced Influenza Vaccines on Direct Healthcare Costs for the U.S. Elderly: A Comprehensive Real-World Evaluation of Adjuvanted Trivalent Influenza Vaccine Compared to Trivalent High-Dose Influenza Vaccine for the 2018–19 Influenza Season
por: Postma, Maarten, et al.
Publicado: (2020)

Temperature in Nursing Home Residents Systematically Tested for SARS-CoV-2
por: Rudolph, James L., et al.
Publicado: (2020)

LONG-TERM CARE FACILITY VARIATION IN THE INCIDENCE OF PNEUMONIA AND INFLUENZA HOSPITALIZATIONS
por: Bosco, Elliott, et al.
Publicado: (2019)

Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents — 19 States, March 29–July 25, 2022
por: McConeghy, Kevin W., et al.
Publicado: (2022)

Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines
por: van Essen, Gerrit A, et al.
Publicado: (2014)

Relative Effect of High-Dose Influenza Vaccination on Hospitalizations of Older Adults in United States Nursing Homes: Results From a Cluster-Randomized Controlled Trial
por: Gravenstein, Stefan, et al.
Publicado: (2015)

Long-term Care Facility Variation in the Incidence of Pneumonia and Influenza
por: Bosco, Elliott, et al.
Publicado: (2019)

Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
por: Cox, Freek, et al.
Publicado: (2015)

1435. The Cost-Effectiveness of Vaccinating With an Adjuvanted Trivalent Influenza Vaccine for the 65+ Population in Argentina
por: Nguyen, Van, et al.
Publicado: (2018)

Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017–2018 and 2018–2019 Influenza Seasons
por: Boikos, Constantina, et al.
Publicado: (2021)

Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection
por: Bardenheier, Barbara H., et al.
Publicado: (2021)

Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States
por: Boikos, Constantina, et al.
Publicado: (2022)

Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice
por: Silveira, Fernando, et al.
Publicado: (2023)

6. MF59 ASSURANCE 2: A Real-world Study to Estimate the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to Egg-based Trivalent High-dose Among U.S. Older Adults During 2018–19 Influenza Season
por: Pelton, Stephen I, et al.
Publicado: (2020)

2730. Estimating Deaths Attributable to Influenza Mortality Using Traditional and Novel Forecasting Methods
por: McConeghy, Kevin, et al.
Publicado: (2019)

Modelling the Economic Impact of lnfluenza Vaccine Programs with the Cell-Based Quadrivalent Influenza Vaccine and Adjuvanted Trivalent Influenza Vaccine in Canada
por: Nguyen, Van Hung, et al.
Publicado: (2022)

Health profiles of 996 melanoma survivors: the M. D. Anderson experience
por: Stava, Charles, et al.
Publicado: (2006)

Economic Assessment of High-Dose Versus Adjuvanted Influenza Vaccine: An Evaluation of Hospitalization Costs Based on a Cohort Study
por: van Aalst, Robertus, et al.
Publicado: (2021)

Adverse Events of Interest Following Influenza Vaccination in the First Season of Adjuvanted Trivalent Immunization: Retrospective Cohort Study
por: de Lusignan, Simon, et al.
Publicado: (2022)

Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
por: Myers, Mallory L., et al.
Publicado: (2022)

Geographic Variation in Pneumonia and Influenza in Long-Term Care Facilities: A National Study
por: Bosco, Elliott, et al.
Publicado: (2020)

996. The Potential for Reducing Opioid and Analgesic Prescriptions Via Herpes Zoster Vaccination
por: Poirrier, Jean-Etienne, et al.
Publicado: (2020)

996. CD4+ T-Cell Lymphopenia Associated with Frequent Plateletpheresis in Healthy Donors
por: Cunningham, Phoebe H, et al.
Publicado: (2021)

Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
por: Myers, Mallory L., et al.
Publicado: (2023)

UGT1A1 Variants c.864+5G>T and c.996+2_996+5del of a Crigler-Najjar Patient Induce Aberrant Splicing in Minigene Assays
por: Gailite, Linda, et al.
Publicado: (2020)

Variation in influenza vaccine assessment, receipt, and refusal by the concentration of Medicare Advantage enrollees in U.S. nursing homes
por: Moyo, Patience, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_508v4tm7ava6meirvotkbj6kg6